Calumet's $1 Billion Shortcut: How a Lease Deal and a Broken Base-Oil Market Reset the Deleveraging Clock

Record Specialty EBITDA and a restructured MaxSAF turn MRL from a forced sale into an option — while Performance Brands quietly eats the cost lag

CLMT · Earnings Call · 2026-11-06

The quarter that bent the trajectory

Calumet's third quarter was not merely a good print for a specialty chemical company; it was the quarter the balance-sheet story changed shape. Adjusted EBITDA with tax attributes came in at $347 million, with Specialty Products and Solutions throwing off $248 million and Montana Renewables a record $80.4 million. Todd Borgmann called it “an exceptional 1” — Louis Todd Borgmann, Chief Executive Officer · 2026-11-06 and said the company's “deleveraging and growth strategy is accelerating by years” — Louis Todd Borgmann, Chief Executive Officer · 2026-11-06. That is not boilerplate: consolidated net leverage stood at roughly 3x at quarter end, down from over 9x at the beginning of last year, and net recourse leverage at the restricted group was about 2.3x after paying down nearly $550 million of recourse notes and revolver borrowings. In four months Calumet retired roughly $265 million of debt, saving about $26 million of annual cash interest. The reported fundamentals still describe the old Calumet, because the latest 10-Q covers the June quarter: Total Revenue of $1.445 billion, a Gross Margin of 1.3%, operating income of -$117 million, and Effective Net Cash of -$2.2 billion against a Liabilities to Assets ratio of 131.6%. That is exactly the point. This is the first call where cash generation is large enough to visibly bend the trajectory rather than promise it.

A physical shortage, not a trading squeeze

The specialty business is the engine, and the setup is unusually concrete. More than 10% of global paraffinic base oil capacity is damaged: roughly a third from Group 1 plants, a third from Middle Eastern capacity tied to the Middle East Conflict, and a third from Europe's Group 1 capacity lost through the Russia-Ukraine war. Scott Obermeier did not hedge: “we view the impact globally as not a quick fix... tighter market for longer because it is gonna take time to get rebuilt and then replenish global supply chains” — Scott Obermeier, Unknown · 2026-11-06. Plants take quarters to repair, recommission and requalify — and then inventories drawn down all year have to be refilled at prices that never incentivized refilling. Calumet sits on the right side of that physics. Its crude is domestic crude, nearby and readily available, and the integrated system captures the intermediate value uplift that non-integrated producers are paying up for. The company posted its eighth consecutive quarter of specialty sales above 20,000 barrels per day, and management now speaks of that level as a floor. The Shreveport turnaround finished on time and on budget in early November; Todd noted the company was limping into it in the mid-forties thousand barrels per day and expects to be “running in the fifties of thousands barrels a day making our own feedstock” — Louis Todd Borgmann, Chief Executive Officer · 2026-11-06 coming out. That is why the current margin environment can plausibly persist into next year rather than mean-revert on a quarter's notice.

MaxSAF gets cheaper, and MRL gets optionality

The second structural change is at Montana Renewables, where the MaxSAF expansion was re-engineered from a capital-heavy project into something far lighter. The new agreement with the Department of Energy and Warburg Pincus turns CMR's existing equipment into a leased asset for MRL. David Lunin said the structure provides “an expected $30 million annual lease payment to CMR from MRL” — David Lunin, EVP and Chief Financial Officer · 2026-11-06 and saves “roughly $1 billion of capital compared to the original plan” — David Lunin, EVP and Chief Financial Officer · 2026-11-06. Warburg's preferred return rises to 11.5%, but its 13.2% common equity position collapses into a warrant to buy 8% of MRL at a $750 million equity strike. CMR keeps a fixed cash flow stream; MRL keeps the assets. Operationally the MaxSAF expansion is now a sequence of small, controllable steps. The naphtha splitter, the hydrogen plant and the hydrotreater are being tied into MRL this month, which should cut naphtha yield, lift the price on what remains, relieve the hydrogen rate-limiter by roughly a thousand barrels a day, and enable the new SAF polishing service. The published ramp is an 80 million gallon annual SAF run rate by year end, 120 million-plus by spring, 120-150 million by the end of 2027, and 200 million gallons in 2028, with total throughput creeping toward 17,000 barrels per day. The Warburg Pincus partnership remains central, but the economics now favor the parent. The strategic implication is larger than the lease. For several quarters management framed MRL monetization as the ultimate deleveraging instrument. In May, Todd said the plan “still remains as it has been” — Louis Borgmann, Chief Executive Officer · 2026-05-08 and that MRL would “present an opportunity to monetize” — Louis Borgmann, Chief Executive Officer · 2026-05-08. By August the framing had softened: “we no longer have to do it as a prerequisite to grow our specialties business” — Louis Borgmann, CEO · 2026-08-07. On this call it softened again:

monetization remains an option. Long term, we think of that as the most likely scenario. But I would say the idea of pushing that solely to drive accelerated deleveraging of the restricted group is not a requirement. Our eyes are on maximizing shareholder value.
Louis Todd Borgmann, Chief Executive Officer · 2026-11-06

That is a genuine change in urgency. The cash engine is now strong enough that MRL can be sold or floated on value rather than necessity — the opposite of the 2024-25 posture, when the asset was effectively collateral for a balance sheet problem.

The lag, the leverage, and what to watch

The blemish is Performance Brands. Adjusted EBITDA fell to $9.1 million from $13.2 million a year ago even as volumes rose to 6.8 million gallons from 6.3 million. Input costs are outrunning retail channel pricing, which carries a 60- to 90-day lag. Todd was blunt about the trade-off: “Obviously, it is a big headwind for performance brands and chasing the cost increase up. But on the SPS side, obviously, it is super beneficial” — Louis Todd Borgmann, Chief Executive Officer · 2026-11-06. With specialty production roughly 35x the size of Performance Brands, that is a trade shareholders should accept — though it does mean the segment stays noisy while raw materials climb. The deleveraging runway is the thing to monitor. The remaining $175 million of 2028 notes sit directly in front of them, and the 2029s become callable at par in January. The proof point is cash: Free Cash Flow (less SBC) swung to $46 million in Q2 from -$137 million in Q1, and Q3's earnings power should be materially larger, though working capital and turnaround downtime will swing the timing. And then there is the mid cycle question, where Todd argued the through-cycle number has structurally risen: “I do think that our mid cycle has increased. Hard to put a specific dollar amount on that, but it has increased in 2 ways” — Louis Todd Borgmann, Chief Executive Officer · 2026-11-06 — less debt on the same EBITDA, plus reliability and growth capital in specialties. He explicitly declined to call $150 million of SPS EBITDA the new normal, which is the right kind of caution. The stock tells you the market is still arguing with itself. Shares are up 8.8% over the last 90 days but 32.9% below the September 17 peak of $59.05, a drawdown that says investors are pricing both the durability of specialty margins and the execution risk around the November tie-in. This quarter does not eliminate either risk. It does shift the burden of proof: Calumet no longer needs a miracle to accelerated deleveraging — it needs the physical shortage to last long enough and the MaxSAF steps to land as scheduled. Both look more likely after this call than before it.